Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

Last updated on 2022-12-13 History
Report ID 167948
Drug Identification Number 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name THIAMINE HYDROCHLORIDE INJECTION 100MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) THIAMINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 10mL vial / fiole
ATC code A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-09-08
Actual start date 2022-09-16
Estimated end date 2022-12-16
Actual end date 2022-12-12
Shortage status Resolved
Updated date 2022-12-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-12-13 English Compare
v15 2022-12-12 French Compare
v14 2022-12-12 English Compare
v13 2022-12-02 French Compare
v12 2022-12-02 English Compare
v11 2022-11-18 French Compare
v10 2022-11-18 English Compare
v9 2022-11-11 French Compare
v8 2022-11-11 English Compare
v7 2022-11-04 French Compare
v6 2022-11-04 English Compare
v5 2022-09-23 French Compare
v4 2022-09-23 English Compare
v3 2022-09-18 French Compare
v2 2022-09-18 English Compare
v1 2022-08-25 English Compare

Showing 1 to 16 of 16